Botanix Receives Capital Raise Commitments of A$45 Million
Filed with ASX · · 17 pages · English
Watch Botanix Pharmaceuticals' latest callBotanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call · Replay · Mar 2Read the transcript of Botanix Pharmaceuticals (ASX:BOT) Q2 2026 Earnings Call1. Botanix has received firm commitments for a ~A$40 million two-tranche Placement, strongly supported by existing and new institutional and sophisticated investors, with the second tranche subject to shareholder approval 2. The Company also intends to offer existing eligible shareholders the opportunity to partake in a security purchase plan underwritten up to A$5 million (before costs), with the
Botanix Pharmaceuticals Limited on 6ix
In the deck
Earlier from Botanix Pharmaceuticals
- Trading Halt
- Pause in Trading
- Botanix Quarterly Activities Report and Appendix 4C Q2 FY26
- Botanix Quarterly Activities Report and Appendix 4C Q1 FY26
- Appendix 4E & Annual Report for the Year Ended 30 June 2025
Later from Botanix Pharmaceuticals
- Appendix 4D and Half Year Report
- S&P DJI Announces March 2026 Quarterly Rebalance
- Successful renegotiation of API supply agreement
- Botanix reaches term sheet agreement with 2nd API supplier
- Botanix Quarterly Activities Report and Appendix 4C Q3 FY26
Follow Botanix Pharmaceuticals into a list and get an email when it puts out news.
Follow Botanix Pharmaceuticals